The Bill and Melinda Gates Foundation awarded $4.4 million to the VCU School of Engineering to collaborate with other research universities on an opportunity to supply developing countries with affordable access to AIDS drugs. . Frank Gupton is an engineering research professor and chairs the Dept. of Chemical and Life Science Engineering. With his extensive experience in pharmaceutical process development, Gupton is the principal investigator for the team. He said the World Health Organization considers nevirapine a first line therapy for the treatment of AIDS. The mission is to come up with a dramatic change in pharmeutical manufacturing technology. To indentify a manufacturing route leading to nevirapine that employs the lowest cost raw materials and ultraefficient manufacturing tools. In the US, most people today aren’t aware, Gupton said, of the extent of what is still an epidemic disease globally.